स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 500 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.12 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 850 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (rubrum), pro compresso obducto corresp. natrium 1.93 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

xiromed sa - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 2.32 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sitagliptinum, metformini hydrochloridum - compresse a rilascio modificati - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 500 mg, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 2.147 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sitagliptinum, metformini hydrochloridum - compresse a rilascio modificati - sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, pro compresso obducto corresp. natrium 2.147 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - sitagliptinum, metformini hydrochloridum - compresse a rilascio modificati - sitagliptinum 100 mg ut sitagliptini hydrochloridum monohydricum, metformini hydrochloridum 1000 mg, hypromellosum, magnesii stearas, calcii hydrogenophosphas, cellulosum microcristallinum, natrii stearylis fumaras, carmellosum natricum conexum, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.427 mg. - il diabete mellito di tipo 2 - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 500.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 0.7 mg. - farmaco antidiabetico orale - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 850.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.1 mg. - farmaco antidiabetico orale - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

axapharm ag - sitagliptinum, metformini hydrochloridum - compresse rivestite con film - sitagliptini hydrochloridum 54.484 mg ut sitagliptini hydrochloridum monohydricum corresp. sitagliptinum 50.000 mg, metformini hydrochloridum 1000.000 mg, cellulosum microcristallinum, povidonum, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogola, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 1.3 mg. - farmaco antidiabetico orale - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - metformini hydrochloridum, sitagliptinum - compresse rivestite con film - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.025 mg. - diabetes typ 2 - synthetika